Dr. Stefanacci explains the new rules for Medicare’s Part D drug benefit for the year 2007 and offers strategies for reducing out-of-pocket expenses for beneficiaries.
You are here
P&T® Journal contents for January 2007
Augmentation and Combination Pharmacotherapy Trends in Major Depressive Disorder: Results of a Brief Survey of Psychiatrists
The authors present the results of a brief audience participation survey of 601 psychiatrists about their practices of prescribing antidepressants and discuss the use of first-line, second-line, and third-line treatment options.
Managing Hypertension in Patients with or without Comorbidities in a Teaching Hospital Outpatient Setting
Patients were able to achieve reductions of blood pressure, glycosylated hemoglobin, and low-density lipoprotein-cholesterol, according to the authors, because physicians adhered to national guidelines and spent “quality time” with these patients.
Dr. Goldenberg discusses the current status of targeted therapies for colorectal cancer; novel biologic agents that target angiogenesis and growth factors; a monoclonal antibody for colon and pancreatic cancer; and kinase-targeted drugs for gastrointestinal stromal tumors.
The authors review the cardiovascular risks of commonly used painkillers and present the latest findings on acute myocardial infarction, atrial fibrillation in hypertension, cardiovascular disease in diabetes patients, non–ST-segment elevation in acute coronary syndrome, and familial hypercholesterolemia. The controversial torcetrapib/atorvastatin (Lipitor) combination is also discussed.